Search

everythinglearnresearchcommunity

for

Search:↓

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Most people using minoxidil for hair loss probably won't see significant improvement.

Combining PRP with Minoxidil improves hair density and thickness more than Minoxidil alone.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Minoxidil and finasteride work best for hair loss; more research needed.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Off-label drug use can be risky but sometimes beneficial when standard treatments fail.

Health warnings and public health actions led to a significant drop in flutamide prescriptions for women, but off-label use still continues.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

Home-based skin care devices are generally safe and effective for hair removal, promoting hair growth, treating wrinkles and acne, but results for psoriasis treatment are mixed.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Botulinum toxins are safe for various medical and cosmetic uses, but more research is needed for long-term safety and effectiveness in hair growth treatments.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Low-dose oral minoxidil is a safe treatment for hair loss, with the main side effect being excessive hair growth. Other side effects like foot swelling, low blood pressure when standing, and heart rate changes are rare.

Photobiomodulation therapy significantly increases hair density and growth for androgenic alopecia, but more research is needed to confirm safety.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Spironolactone can effectively treat hair loss with manageable side effects.

Fat tissue treatments may help with wound healing and hair growth, but more research with larger groups is needed to be sure.

Combination therapies work better than single treatments for hair loss.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Cannabinoids may help some skin conditions but more research is needed.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

Terbinafine is the most effective treatment for tinea capitis, a scalp infection often confused with other conditions.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.